| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACIN1
|
apoptotic chromatin condensation inducer 1
|
|
ACVR1B
|
activin A receptor, type IB
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADD2
|
adducin 2 (beta)
|
|
ADK
|
adenosine kinase
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKTIP
|
AKT interacting protein
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANP32B
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B
|
|
ANTXR1
|
anthrax toxin receptor 1
|
|
ANTXR2
|
anthrax toxin receptor 2
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
APC
|
adenomatous polyposis coli
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP5
|
aquaporin 5
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARRB1
|
arrestin, beta 1
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BANP
|
BTG3 associated nuclear protein
|
|
BAX
|
BCL2-associated X protein
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BLVRA
|
biliverdin reductase A
|
|
BORA
|
bora, aurora kinase A activator
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C2CD5
|
C2 calcium-dependent domain containing 5
|
|
C5AR2
|
complement component 5a receptor 2
|
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
|
CACYBP
|
calcyclin binding protein
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBY1
|
chibby homolog 1 (Drosophila)
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD5
|
CD5 molecule
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC6
|
cell division cycle 6
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHN2
|
chimerin 2
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIC
|
capicua transcriptional repressor
|
|
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
CSRP2
|
cysteine and glycine-rich protein 2
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CUL5
|
cullin 5
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEF6
|
differentially expressed in FDCP 6 homolog (mouse)
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
DGKD
|
diacylglycerol kinase, delta 130kDa
|
|
DNM1L
|
dynamin 1-like
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DRD1
|
dopamine receptor D1
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DUSP5
|
dual specificity phosphatase 5
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ESR1
|
estrogen receptor 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV6
|
ets variant 6
|
|
EZR
|
ezrin
|
|
FAS
|
Fas cell surface death receptor
|
|
FBXW8
|
F-box and WD repeat domain containing 8
|
|
FGB
|
fibrinogen beta chain
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FLNA
|
filamin A, alpha
|
|
FLOT2
|
flotillin 2
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXO6
|
forkhead box O6
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FUS
|
FUS RNA binding protein
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAP43
|
growth associated protein 43
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GATA2
|
GATA binding protein 2
|
|
GATA4
|
GATA binding protein 4
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTA4
|
glutathione S-transferase alpha 4
|
|
GTF2I
|
general transcription factor IIi
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
GYS2
|
glycogen synthase 2 (liver)
|
|
H2AFX
|
H2A histone family, member X
|
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
|
HDAC5
|
histone deacetylase 5
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HMGB1
|
high mobility group box 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL1A
|
interleukin 1, alpha
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
ILK
|
integrin-linked kinase
|
|
INCENP
|
inner centromere protein antigens 135/155kDa
|
|
INSR
|
insulin receptor
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KDR
|
kinase insert domain receptor
|
|
KIDINS220
|
kinase D-interacting substrate, 220kDa
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF16
|
Kruppel-like factor 16
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LPXN
|
leupaxin
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MARS
|
methionyl-tRNA synthetase
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEFV
|
Mediterranean fever
|
|
MIP
|
major intrinsic protein of lens fiber
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MSN
|
moesin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
MYL7
|
myosin, light chain 7, regulatory
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYLK
|
myosin light chain kinase
|
|
MYO5A
|
myosin VA (heavy chain 12, myoxin)
|
|
NACA
|
nascent polypeptide-associated complex alpha subunit
|
|
NAGK
|
N-acetylglucosamine kinase
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NEUROG2
|
neurogenin 2
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
|
NGFR
|
nerve growth factor receptor
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRGN
|
neurogranin (protein kinase C substrate, RC3)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OCLN
|
occludin
|
|
OLIG1
|
oligodendrocyte transcription factor 1
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
OSBP
|
oxysterol binding protein
|
|
P2RX6
|
purinergic receptor P2X, ligand gated ion channel, 6
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX3
|
paired box 3
|
|
PDC
|
phosducin
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PER1
|
period circadian clock 1
|
|
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
|
|
PGR
|
progesterone receptor
|
|
PHF20
|
PHD finger protein 20
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIP5K1B
|
phosphatidylinositol-4-phosphate 5-kinase, type I, beta
|
|
PITPNM1
|
phosphatidylinositol transfer protein, membrane-associated 1
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
PLK1
|
polo-like kinase 1
|
|
PLN
|
phospholamban
|
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD3
|
protein kinase D3
|
|
PRLR
|
prolactin receptor
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PSMC5
|
proteasome (prosome, macropain) 26S subunit, ATPase, 5
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)
|
|
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7
|
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PXN
|
paxillin
|
|
RAB11A
|
RAB11A, member RAS oncogene family
|
|
RAB11FIP3
|
RAB11 family interacting protein 3 (class II)
|
|
RAB4A
|
RAB4A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG2
|
recombination activating gene 2
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RALGAPA2
|
Ral GTPase activating protein, alpha subunit 2 (catalytic)
|
|
RANBP3
|
RAN binding protein 3
|
|
RB1
|
retinoblastoma 1
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RDX
|
radixin
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RET
|
ret proto-oncogene
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RGCC
|
regulator of cell cycle
|
|
RGS10
|
regulator of G-protein signaling 10
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHOA
|
ras homolog family member A
|
|
RHOQ
|
ras homolog family member Q
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RPS3
|
ribosomal protein S3
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RRN3
|
RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A11
|
S100 calcium binding protein A11
|
|
SEC63
|
SEC63 homolog (S. cerevisiae)
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFN
|
stratifin
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2B2
|
SH2B adaptor protein 2
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SH3GL2
|
SH3-domain GRB2-like 2
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIK1
|
salt-inducible kinase 1
|
|
SIK2
|
salt-inducible kinase 2
|
|
SKAP1
|
src kinase associated phosphoprotein 1
|
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC38A3
|
solute carrier family 38, member 3
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLK
|
STE20-like kinase
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNAP23
|
synaptosomal-associated protein, 23kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SRPK2
|
SRSF protein kinase 2
|
|
SRR
|
serine racemase
|
|
SSBP3
|
single stranded DNA binding protein 3
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIP1
|
stress-induced phosphoprotein 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK17B
|
serine/threonine kinase 17b
|
|
STK3
|
serine/threonine kinase 3
|
|
STK38
|
serine/threonine kinase 38
|
|
STK4
|
serine/threonine kinase 4
|
|
STMN1
|
stathmin 1
|
|
STRAP
|
serine/threonine kinase receptor associated protein
|
|
STXBP3
|
syntaxin binding protein 3
|
|
STXBP4
|
syntaxin binding protein 4
|
|
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
|
|
SYN2
|
synapsin II
|
|
SYT4
|
synaptotagmin IV
|
|
TAGLN
|
transgelin
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAL2
|
T-cell acute lymphocytic leukemia 2
|
|
TAOK2
|
TAO kinase 2
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBC1D1
|
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
TCP1
|
t-complex 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THOC5
|
THO complex 5
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TNP2
|
transition protein 2 (during histone to protamine replacement)
|
|
TOB1
|
transducer of ERBB2, 1
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTK
|
TTK protein kinase
|
|
TXK
|
TXK tyrosine kinase
|
|
TYK2
|
tyrosine kinase 2
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
USF1
|
upstream transcription factor 1
|
|
USP10
|
ubiquitin specific peptidase 10
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCP
|
valosin containing protein
|
|
VIM
|
vimentin
|
|
WASF2
|
WAS protein family, member 2
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WNK2
|
WNK lysine deficient protein kinase 2
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XBP1
|
X-box binding protein 1
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZC3HC1
|
zinc finger, C3HC-type containing 1
|
|
ZYX
|
zyxin
|
